PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 2, 2024Cancer Research

Abstract PO3-14-06: Immunologic features and association with prognosis in hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with chemotherapy (CT) or CDK4/6-inhibitors (CDK4/6i) + endocrine therapy (ET)

View Full Paper
Ask AI
Bookmark
Share

Authors

FSFrancesco SchettiniMPMichela PalleschiFMFrancesca Mannozzi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schettini et al. (2024) studied this question.

synapsesocial.com/papers/68e6be91b6db64358763e543https://doi.org/10.1158/1538-7445.sabcs23-po3-14-06
View Full Paper
Ask AI
Bookmark
Share